News and Announcements
3 Important Traits That Separate The Top 10% Founders
- Published December 20, 2022 12:11AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
The 3 most important traits that Michael Seibel from Y Combinator see that separate the top 10% founders from everyone else:
1. Great founders execute: They never get stuck in the execution step, instead, they figure out a way to get things done.
2. Formidability: Formidable founders are the ones that get things done over and over again, consistently. You treat them with more respect as you know their potential of turning ideas into substantial actions.
3. Communication: Startups require good communication with your users, potential employees, investors to get people excited about it. The best founders can in one or two sentences explain what the business does to anyone at any industry knowledge.
Bonus: Internal motivation. They don’t get too discouraged when things go wrong. They stay passionate about the product, about finding a solution, even after making mistakes and bad decisions over and over again (which will happen)
Click here to view the original Linkedin post.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
